Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation

LEUKEMIA

NATURE PUBLISHING GROUP

1. Leukemia & Lymphoma Society (Translational Research Program) [6489-16]
2. Alex's Lemonade Stand Foundation/Cure4Cam Childhood Cancer Foundation
3. Hyundai Hope on Wheels
4. Bezos Family Immunotherapy Initiative
5. National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health [NIDDK/NIH: P30-DK56465]
6. National Heart, Lung, and Blood Institute/NIH [NHLBI/NIH: T32-HL007093]